[A Case Study of Severe Myelosuppression Induced by Adjuvant Chemotherapy in a Breast Cancer Patient with Concurrent Immune Thrombocytopenia(ITP)].
Аннотация
This report describes 2 cases of breast cancer complicated by immune thrombocytopenia(ITP), both developing severe myelosuppression during adjuvant chemotherapy. Case 1 involved a 72-year-old woman(cT3N3M0, Stage ⅢC, ER-negative, HER2-negative)who underwent mastectomy with axillary dissection. Following completion of weekly paclitaxel(PTX), initiation of epirubicin plus cyclophosphamide(EC)resulted in a marked platelet decrease to 1.3×104/μL on day 7, necessitating repeated platelet transfusions. Case 2 involved a 65-year-old woman(cT2N0M0, Stage ⅡA, ER-negative, HER2- positive)treated with mastectomy and sentinel node biopsy. After completing PTX plus anti-HER2 therapy, EC administration similarly led to severe thrombocytopenia(1.7×104/μL). In both cases, neoadjuvant chemotherapy was considered, but due to underlying ITP, primary surgery was selected. Severe thrombocytopenia during the first EC cycle led to treatment discontinuation. These findings suggest that in breast cancer patients with ITP, neoadjuvant chemotherapy may not be feasible, and primary surgical intervention should be considered. Furthermore, when administering EC, vigilant hematological monitoring is imperative.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.